Skip to main content
Top
Published in: BMC Health Services Research 1/2019

Open Access 01-12-2019 | Care | Research article

Patient and provider perspectives on how trust influences maternal vaccine acceptance among pregnant women in Kenya

Authors: Stacy W. Nganga, Nancy A. Otieno, Maxwell Adero, Dominic Ouma, Sandra S. Chaves, Jennifer R. Verani, Marc-Alain Widdowson, Andrew Wilson, Irina Bergenfeld, Courtni Andrews, Vincent L. Fenimore, Ines Gonzalez-Casanova, Paula M. Frew, Saad B. Omer, Fauzia A. Malik

Published in: BMC Health Services Research | Issue 1/2019

Login to get access

Abstract

Background

Pregnant women and newborns are at high risk for infectious diseases. Altered immunity status during pregnancy and challenges fully vaccinating newborns contribute to this medical reality. Maternal immunization is a strategy to protect pregnant women and their newborns. This study aimed to find out how patient-provider relationships affect maternal vaccine uptake, particularly in the context of a lower middle- income country where limited research in this area exists.

Methods

We conducted semi-structured, in-depth narrative interviews of both providers and pregnant women from four sites in Kenya: Siaya, Nairobi, Mombasa, and Marsabit. Interviews were conducted in either English or one of the local regional languages.

Results

We found that patient trust in health care providers (HCPs) is integral to vaccine acceptance among pregnant women in Kenya. The HCP-patient relationship is a fiduciary one, whereby the patients’ trusts is primarily rooted in the provider’s social position as a person who is highly educated in matters of health. Furthermore, patient health education and provider attitudes are crucial for reinstating and fostering that trust, especially in cases where trust was impeded by rumors, community myths and misperceptions, and religious and cultural factors.

Conclusion

Patient trust in providers is a strong facilitator contributing to vaccine acceptance among pregnant women in Kenya. To maintain and increase immunization trust, providers have a critical role in cultivating a positive environment that allows for favorable interactions and patient health education. This includes educating providers on maternal immunizations and enhancing knowledge of effective risk communication tactics in clinical encounters.
Appendix
Available only for authorised users
Literature
1.
2.
go back to reference Vojtek I, Dieussaert I, Doherty TM, Franck V, Hanssens L, Miller J, Bekkat-Berkani R, Kandeil W, Prado-Cohrs D, Vyse A. Maternal immunization: where are we now and how to move forward? Ann Med. 2018;50(3):193–208.CrossRef Vojtek I, Dieussaert I, Doherty TM, Franck V, Hanssens L, Miller J, Bekkat-Berkani R, Kandeil W, Prado-Cohrs D, Vyse A. Maternal immunization: where are we now and how to move forward? Ann Med. 2018;50(3):193–208.CrossRef
4.
go back to reference Pathirana J, Nkambule J, Black S. Determinants of maternal immunization in developing countries. Vaccine. 2015;33(26):2971–7.CrossRef Pathirana J, Nkambule J, Black S. Determinants of maternal immunization in developing countries. Vaccine. 2015;33(26):2971–7.CrossRef
6.
go back to reference Wilson RJ, Paterson P, Jarrett C, Larson HJ. Understanding factors influencing vaccination acceptance during pregnancy globally: a literature review. Vaccine. 2015;33(47):6420–9.CrossRef Wilson RJ, Paterson P, Jarrett C, Larson HJ. Understanding factors influencing vaccination acceptance during pregnancy globally: a literature review. Vaccine. 2015;33(47):6420–9.CrossRef
7.
go back to reference Vaccines against influenza WHO position paper - November 2012. Releve Epidemiologique Hebdomadaire. 2012;87(47):461–76. Vaccines against influenza WHO position paper - November 2012. Releve Epidemiologique Hebdomadaire. 2012;87(47):461–76.
8.
go back to reference Ortiz JR, Neuzil KM, Ahonkhai VI, Gellin BG, Salisbury DM, Read JS, Adegbola RA, Abramson JS. Translating vaccine policy into action: a report from the Bill & Melinda Gates Foundation Consultation on the prevention of maternal and early infant influenza in resource-limited settings. Vaccine. 2012;30(50):7134–40.CrossRef Ortiz JR, Neuzil KM, Ahonkhai VI, Gellin BG, Salisbury DM, Read JS, Adegbola RA, Abramson JS. Translating vaccine policy into action: a report from the Bill & Melinda Gates Foundation Consultation on the prevention of maternal and early infant influenza in resource-limited settings. Vaccine. 2012;30(50):7134–40.CrossRef
9.
go back to reference MacDougall DM, Halperin SA. Improving rates of maternal immunization: challenges and opportunities. Hum Vaccin Immunother. 2016;12(4):857–65.CrossRef MacDougall DM, Halperin SA. Improving rates of maternal immunization: challenges and opportunities. Hum Vaccin Immunother. 2016;12(4):857–65.CrossRef
10.
go back to reference Donders GG, Halperin SA, Devlieger R, Baker S, Forte P, Wittke F, Slobod KS, Dull PM. Maternal immunization with an investigational trivalent group B streptococcal vaccine: a randomized controlled trial. Obstet Gynecol. 2016;127(2):213–21.CrossRef Donders GG, Halperin SA, Devlieger R, Baker S, Forte P, Wittke F, Slobod KS, Dull PM. Maternal immunization with an investigational trivalent group B streptococcal vaccine: a randomized controlled trial. Obstet Gynecol. 2016;127(2):213–21.CrossRef
11.
go back to reference Madhi SA, Cutland CL, Jose L, Koen A, Govender N, Wittke F, Olugbosi M, Meulen AS, Baker S, Dull PM, et al. Safety and immunogenicity of an investigational maternal trivalent group B streptococcus vaccine in healthy women and their infants: a randomised phase 1b/2 trial. Lancet Infect Dis. 2016;16(8):923–34.CrossRef Madhi SA, Cutland CL, Jose L, Koen A, Govender N, Wittke F, Olugbosi M, Meulen AS, Baker S, Dull PM, et al. Safety and immunogenicity of an investigational maternal trivalent group B streptococcus vaccine in healthy women and their infants: a randomised phase 1b/2 trial. Lancet Infect Dis. 2016;16(8):923–34.CrossRef
12.
go back to reference Madhi SA, Dangor Z, Heath PT, Schrag S, Izu A, Sobanjo-Ter Meulen A, Dull PM. Considerations for a phase-III trial to evaluate a group B Streptococcus polysaccharide-protein conjugate vaccine in pregnant women for the prevention of early- and late-onset invasive disease in young-infants. Vaccine. 2013;31(Suppl 4):D52–7.CrossRef Madhi SA, Dangor Z, Heath PT, Schrag S, Izu A, Sobanjo-Ter Meulen A, Dull PM. Considerations for a phase-III trial to evaluate a group B Streptococcus polysaccharide-protein conjugate vaccine in pregnant women for the prevention of early- and late-onset invasive disease in young-infants. Vaccine. 2013;31(Suppl 4):D52–7.CrossRef
13.
go back to reference Rieder F, Steininger C. Cytomegalovirus vaccine: phase II clinical trial results. Clin Microbiol Infect. 2014;20(Suppl 5):95–102.CrossRef Rieder F, Steininger C. Cytomegalovirus vaccine: phase II clinical trial results. Clin Microbiol Infect. 2014;20(Suppl 5):95–102.CrossRef
14.
go back to reference Glenn GM, Fries LF, Thomas DN, Smith G, Kpamegan E, Lu H, Flyer D, Jani D, Hickman SP, Piedra PA. A randomized, blinded, controlled, dose-ranging study of a respiratory syncytial virus recombinant fusion (F) nanoparticle vaccine in healthy women of childbearing age. J Infect Dis. 2016;213(3):411–22.CrossRef Glenn GM, Fries LF, Thomas DN, Smith G, Kpamegan E, Lu H, Flyer D, Jani D, Hickman SP, Piedra PA. A randomized, blinded, controlled, dose-ranging study of a respiratory syncytial virus recombinant fusion (F) nanoparticle vaccine in healthy women of childbearing age. J Infect Dis. 2016;213(3):411–22.CrossRef
15.
go back to reference Glenn GM, Smith G, Fries L, Raghunandan R, Lu H, Zhou B, Thomas DN, Hickman SP, Kpamegan E, Boddapati S, et al. Safety and immunogenicity of a Sf9 insect cell-derived respiratory syncytial virus fusion protein nanoparticle vaccine. Vaccine. 2013;31(3):524–32.CrossRef Glenn GM, Smith G, Fries L, Raghunandan R, Lu H, Zhou B, Thomas DN, Hickman SP, Kpamegan E, Boddapati S, et al. Safety and immunogenicity of a Sf9 insect cell-derived respiratory syncytial virus fusion protein nanoparticle vaccine. Vaccine. 2013;31(3):524–32.CrossRef
16.
go back to reference Foley G, Timonen V. Using grounded theory method to capture and analyze health care experiences. Health Serv Res. 2015;50(4):1195–210.CrossRef Foley G, Timonen V. Using grounded theory method to capture and analyze health care experiences. Health Serv Res. 2015;50(4):1195–210.CrossRef
17.
go back to reference Habicht JP. Comparing the quality of indicators of nutritional status by receiver operating characteristic analysis or by standardized differences. Am J Clin Nutr. 2000;71(3):672–3.CrossRef Habicht JP. Comparing the quality of indicators of nutritional status by receiver operating characteristic analysis or by standardized differences. Am J Clin Nutr. 2000;71(3):672–3.CrossRef
19.
go back to reference Kenya National Bureau of Statistics; Kenya Ministry of Health; Kenya National AIDS Control Council; Kenya Medical Research Institute; Kenya National Council for Population and Development; ICF International. Kenya Demographic and Health Survey 2016. http://dhsprogram.com/pubs/pdf/FR308/FR308.pdf. Accessed 15 Oct 2019. Kenya National Bureau of Statistics; Kenya Ministry of Health; Kenya National AIDS Control Council; Kenya Medical Research Institute; Kenya National Council for Population and Development; ICF International. Kenya Demographic and Health Survey 2016. http://​dhsprogram.​com/​pubs/​pdf/​FR308/​FR308.​pdf. Accessed 15 Oct 2019.
20.
go back to reference Marcus JA. Patient-Physician Relationships. In: . Philosophy and Medicine, vol 99. Springer, Dordrecht. In: Humanizing Modern Medicine. Volume 99, edn. Dordrecht; 2008. Marcus JA. Patient-Physician Relationships. In: . Philosophy and Medicine, vol 99. Springer, Dordrecht. In: Humanizing Modern Medicine. Volume 99, edn. Dordrecht; 2008.
21.
go back to reference Streefland P, Chowdhury AM, Ramos-Jimenez P. Patterns of vaccination acceptance. Soc Sci Med. 1999;49(12):1705–16.CrossRef Streefland P, Chowdhury AM, Ramos-Jimenez P. Patterns of vaccination acceptance. Soc Sci Med. 1999;49(12):1705–16.CrossRef
22.
go back to reference Rosenstock IM, Strecher VJ, Becker MH. Social learning theory and the health belief model. Health Educ Q. 1988;15(2):175–83.CrossRef Rosenstock IM, Strecher VJ, Becker MH. Social learning theory and the health belief model. Health Educ Q. 1988;15(2):175–83.CrossRef
23.
go back to reference Ozawa S, Paina L, Qiu M. Exploring pathways for building trust in vaccination and strengthening health system resilience. BMC Health Serv Res. 2016;16(Suppl 7):639.CrossRef Ozawa S, Paina L, Qiu M. Exploring pathways for building trust in vaccination and strengthening health system resilience. BMC Health Serv Res. 2016;16(Suppl 7):639.CrossRef
24.
go back to reference Dube E, Laberge C, Guay M, Bramadat P, Roy R, Bettinger J. Vaccine hesitancy: an overview. Hum Vaccines Immunother. 2013;9(8):1763–73.CrossRef Dube E, Laberge C, Guay M, Bramadat P, Roy R, Bettinger J. Vaccine hesitancy: an overview. Hum Vaccines Immunother. 2013;9(8):1763–73.CrossRef
Metadata
Title
Patient and provider perspectives on how trust influences maternal vaccine acceptance among pregnant women in Kenya
Authors
Stacy W. Nganga
Nancy A. Otieno
Maxwell Adero
Dominic Ouma
Sandra S. Chaves
Jennifer R. Verani
Marc-Alain Widdowson
Andrew Wilson
Irina Bergenfeld
Courtni Andrews
Vincent L. Fenimore
Ines Gonzalez-Casanova
Paula M. Frew
Saad B. Omer
Fauzia A. Malik
Publication date
01-12-2019
Publisher
BioMed Central
Keyword
Care
Published in
BMC Health Services Research / Issue 1/2019
Electronic ISSN: 1472-6963
DOI
https://doi.org/10.1186/s12913-019-4537-8

Other articles of this Issue 1/2019

BMC Health Services Research 1/2019 Go to the issue